Epidermal Growth Factor Receptor (Egfr) As A Molecular Determinant Of Glioblastoma Response To Dopamine Receptor 2 (Drd2) Inhibitors
NEURO-ONCOLOGY（2020）
摘要
High EGFR expression is a determinant of poor glioblastoma response to DRD2. This finding should inform future clinical trial designs.
更多查看译文
关键词
DRD2,EGFR,ONC201,anti-DRD2 treatment,efficacy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要